AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

su xin-zhuanDr. Su's laboratory develops and uses genome-wide approaches to study mechanisms of drug resistance, virulence, genome diversity, population genetics, and evolution of malaria parasites. Large numbers of parasite isolates and progeny from genetic crosses are being typed using thousands of single nucleotide polymorphisms (SNPs), and the genotypes are being associated or linked to differences in parasite response to large numbers of chemical compounds and drugs. Dr. Su also uses the rodent malaria parasite Plasmodium yoelii as a model to study virulence factors and disease phenotypes. He has developed a microsatellite genetic map and performed several genetic crosses to identify genes associated with parasite growth, virulence and drug resistance. Other projects include nucleosome position mapping and gene expression regulation, recombination hotspots and conserved motifs that may play a role in genetic recombination, and the roles of ABC transporters in drug resistance.

TPL_asm2013_SEARCH

91147